History of Research on Tumor Angiogenesis - Image 1

£109.20

Springer History of Research on Tumor Angiogenesis

Name: History of Research on Tumor Angiogenesis
Brand: Springer
Price: 109.2 GBP
Availability: InStock

Biomedical Engineering

It has never been this cheap. We have no record of a lower price.

£109 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 51 days • 51 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 51 days • 1 price levels

Days at Price

Price Analysis

Most common price: £109 (51 days, 100.0%)

Price range: £109 - £109

Price levels: 1 different prices over 51 days

Description

In 1971, J. Folkman hypothesized that tumor growth is angiogenesis-dependent. In 2004, the FDA approved the first angiogenesis inhibitor. This book compiles the relevant literature of that history and emphasizes the antiangiogenic approach to treat tumors. From the Back Cover In 1971, J. Folkman published in the "New England Journal of Medicine" a hypothesis that tumor growth is angiogenesis-dependent. Folkman introduced the concept that tumors probably secrete diffusible molecules that could stimulate the growth of new blood vessels toward the tumor and that the resulting tumor neovascularization could conceivably be prevented or interrupted by angiogenesis inhibitors. Solid and haematological tumors consist of an avascular and a subsequent vascular phase. Assuming that this depends on the release of angiogenic factors, acquisition of angiogenic capability can be seen as an expression of progression from neoplastic transformation to tumor growth and metastasis. Beginning in the 1980's, the biopharmaceutical industry began exploiting the field of antiangiogenesis for creating new therapeutic compounds for modulating new blood vessels in tumor growth. In 2004, Avastin (Bevacizumab), a humanized anti-VEGF monoclonal antibody, was the first angiogenesis inhibitor approved by the Food and Drug Administration for the treatment of colorectal cancer. At present, it has been estimated that over 20,000 cancer patients worldwide have received experimental form of antiangiogenic therapy. This book offers a historical account of the relevant literature. It also emphasizes the crucial and paradigmatic role of angiogenesis as a biological process and the significance of antiangiogenic approach for the treatment of tumors.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 9048181569
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Biomedical Engineering
Domain: Amazon UK
Release Date: 19 October 2010
Listed Since: 23 December 2010

Barcode

No barcode data available

Springer History of Research on Tumor Angiogenesis

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

History of Research on Tumor Angiogenesis

Antiangiogenic Cancer Therapy

Antiangiogenic Agents in Cancer Therapy (Cancer Drug Discovery and Development)

Humana Antiangiogenic Agents in Cancer Therapy - 2nd Edition

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

Angiogenesis Inhibition: 180 (Recent Results in Cancer Research, 180)

Angiogenesis: An Integrative Approach from Science to Medicine

Angiogenesis in Health, Disease and Malignancy

Anti-Angiogenesis Drug Discovery and Development: Volume 2

Angiogenesis: Models, Modulators, and Clinical Applications: 298 (NATO Science Series A:, 298)

Angiogenesis: From Basic Science to Clinical Applications

The Biology of Tumors: 9 (Pezcoller Foundation Symposia, 9)

Vascular Surgery in Oncology

Vascular Surgery in Oncology

Processing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis (Colloquium Series on Protein Activation and Cancer)

Guidance Molecules in Cancer and Tumor Angiogenesis (Advances in Cancer Research): Volume 114

Tumor Angiogenesis Assays: Methods and Protocols: 1464 (Methods in Molecular Biology, 1464)

Vascular Development: 283 (Novartis Foundation Symposia)

Angiogenesis Protocols: 1430 (Methods in Molecular Biology, 1430)

Springer Angiogenesis: Biochemical Basis and Therapeutics

Angiogenesis: Molecular Biology, Clinical Aspects: 263 (NATO Science Series A:, 263)

Inflammation and Angiogenesis

Therapeutic Angiogenesis for Vascular Diseases: Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease